NVO logo

Novo Nordisk A/S (NVO) Gross Profit

Annual Gross Profit

$28.53 B
+$7.48 B+35.51%

31 December 2023

NVO Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Gross Profit

$8.84 B
+$501.66 M+6.01%

30 September 2024

NVO Quarterly Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Gross Profit

$33.32 B
+$1.68 B+5.32%

30 September 2024

NVO TTM Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO Gross Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.5%+23.5%+28.4%
3 y3 years+75.6%+88.7%+85.8%
5 y5 years+91.2%+135.5%+120.4%

NVO Gross Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+75.6%at high+88.7%at high+85.8%
5 y5 yearsat high+91.2%at high+137.3%at high+120.4%
alltimeall timeat high>+9999.0%at high+1024.4%at high+4136.5%

Novo Nordisk A/S Gross Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
$8.84 B(+6.0%)
$33.32 B(+5.3%)
June 2024
-
$8.34 B(+3.3%)
$31.63 B(+5.2%)
Mar 2024
-
$8.07 B(+0.2%)
$30.08 B(+5.5%)
Dec 2023
$28.53 B(+35.5%)
$8.06 B(+12.6%)
$28.52 B(+10.0%)
Sept 2023
-
$7.16 B(+5.5%)
$25.94 B(+8.2%)
June 2023
-
$6.79 B(+4.2%)
$23.97 B(+7.9%)
Mar 2023
-
$6.52 B(+19.0%)
$22.22 B(+5.8%)
Dec 2022
$21.05 B(+12.9%)
$5.48 B(+5.4%)
$21.01 B(+2.6%)
Sept 2022
-
$5.19 B(+3.1%)
$20.47 B(+2.5%)
June 2022
-
$5.04 B(-4.9%)
$19.96 B(+3.0%)
Mar 2022
-
$5.30 B(+7.3%)
$19.38 B(+4.1%)
Dec 2021
$18.64 B(+14.8%)
$4.94 B(+5.3%)
$18.62 B(+3.8%)
Sept 2021
-
$4.69 B(+5.2%)
$17.93 B(+3.7%)
June 2021
-
$4.46 B(-1.8%)
$17.29 B(+4.4%)
Mar 2021
-
$4.54 B(+6.8%)
$16.56 B(+2.0%)
Dec 2020
$16.24 B(+6.3%)
$4.25 B(+4.9%)
$16.23 B(+1.5%)
Sept 2020
-
$4.05 B(+8.6%)
$15.98 B(+1.9%)
June 2020
-
$3.73 B(-11.4%)
$15.69 B(-0.4%)
Mar 2020
-
$4.21 B(+5.1%)
$15.75 B(+3.1%)
Dec 2019
$15.28 B(+2.4%)
$4.00 B(+6.6%)
$15.28 B(+1.1%)
Sept 2019
-
$3.75 B(-0.9%)
$15.12 B(+0.8%)
June 2019
-
$3.79 B(+1.4%)
$15.00 B(+0.6%)
Mar 2019
-
$3.74 B(-2.5%)
$14.91 B(-0.1%)
Dec 2018
$14.92 B(+4.2%)
$3.83 B(+5.3%)
$14.92 B(+1.0%)
Sept 2018
-
$3.64 B(-1.4%)
$14.77 B(+0.8%)
June 2018
-
$3.69 B(-1.5%)
$14.66 B(+0.8%)
Mar 2018
-
$3.75 B(+1.8%)
$14.55 B(+2.0%)
Dec 2017
$14.32 B(+1.8%)
$3.69 B(+4.4%)
$14.27 B(+0.8%)
Sept 2017
-
$3.53 B(-1.4%)
$14.16 B(-0.0%)
June 2017
-
$3.58 B(+3.3%)
$14.16 B(+0.2%)
Mar 2017
-
$3.47 B(-3.0%)
$14.13 B(+0.5%)
Dec 2016
$14.06 B(+3.0%)
$3.57 B(+1.2%)
$14.06 B(+0.1%)
Sept 2016
-
$3.53 B(-0.7%)
$14.04 B(+0.8%)
June 2016
-
$3.55 B(+4.6%)
$13.93 B(+0.9%)
Mar 2016
-
$3.40 B(-4.5%)
$13.81 B(+1.2%)
Dec 2015
$13.65 B(+3.1%)
$3.56 B(+4.1%)
$13.64 B(+0.8%)
Sept 2015
-
$3.42 B(-0.5%)
$13.54 B(+0.5%)
June 2015
-
$3.44 B(+6.4%)
$13.47 B(+1.0%)
Mar 2015
-
$3.23 B(-6.5%)
$13.33 B(+1.0%)
Dec 2014
$13.24 B(+7.1%)
$3.45 B(+3.2%)
$13.20 B(+0.9%)
Sept 2014
-
$3.35 B(+1.4%)
$13.08 B(+2.6%)
June 2014
-
$3.30 B(+6.5%)
$12.76 B(+1.5%)
Mar 2014
-
$3.10 B(-7.2%)
$12.57 B(+1.6%)
Dec 2013
$12.36 B(+10.9%)
$3.34 B(+10.6%)
$12.37 B(+2.0%)
Sept 2013
-
$3.02 B(-3.0%)
$12.13 B(+2.3%)
June 2013
-
$3.11 B(+7.5%)
$11.85 B(+3.0%)
Mar 2013
-
$2.90 B(-6.4%)
$11.51 B(+3.3%)
Dec 2012
$11.15 B(+11.0%)
$3.10 B(+12.7%)
$11.14 B(+3.5%)
Sept 2012
-
$2.75 B(-0.9%)
$10.76 B(+2.2%)
June 2012
-
$2.77 B(+9.5%)
$10.54 B(+2.7%)
Mar 2012
-
$2.53 B(-6.8%)
$10.25 B(+2.2%)
DateAnnualQuarterlyTTM
Dec 2011
$10.04 B(+14.9%)
$2.72 B(+7.8%)
$10.03 B(+3.5%)
Sept 2011
-
$2.52 B(+1.2%)
$9.69 B(+3.5%)
June 2011
-
$2.49 B(+7.9%)
$9.36 B(+4.1%)
Mar 2011
-
$2.31 B(-2.8%)
$9.00 B(+3.0%)
Dec 2010
$8.74 B(+14.9%)
$2.37 B(+8.3%)
$8.73 B(+3.6%)
Sept 2010
-
$2.19 B(+3.3%)
$8.43 B(+3.7%)
June 2010
-
$2.12 B(+3.9%)
$8.12 B(+2.8%)
Mar 2010
-
$2.04 B(-1.3%)
$7.90 B(+3.8%)
Dec 2009
$7.61 B(+8.7%)
$2.07 B(+9.6%)
$7.61 B(+3.8%)
Sept 2009
-
$1.89 B(-0.7%)
$7.33 B(+2.1%)
June 2009
-
$1.90 B(+8.6%)
$7.18 B(+1.5%)
Mar 2009
-
$1.75 B(-2.2%)
$7.07 B(+1.5%)
Dec 2008
$7.00 B(+18.6%)
$1.79 B(+3.0%)
$6.97 B(+2.3%)
Sept 2008
-
$1.74 B(-3.0%)
$6.81 B(+4.0%)
June 2008
-
$1.79 B(+8.8%)
$6.55 B(+4.9%)
Mar 2008
-
$1.65 B(+1.0%)
$6.24 B(+5.6%)
Dec 2007
$5.90 B(+20.1%)
$1.63 B(+10.7%)
$5.91 B(+4.7%)
Sept 2007
-
$1.48 B(-0.7%)
$5.64 B(+4.4%)
June 2007
-
$1.49 B(+12.7%)
$5.41 B(+4.3%)
Mar 2007
-
$1.32 B(-3.6%)
$5.18 B(+5.4%)
Dec 2006
$4.91 B(+19.8%)
$1.37 B(+10.4%)
$4.92 B(+5.8%)
Sept 2006
-
$1.24 B(-1.8%)
$4.65 B(+4.2%)
June 2006
-
$1.26 B(+19.6%)
$4.46 B(+5.6%)
Mar 2006
-
$1.05 B(-3.9%)
$4.23 B(+3.5%)
Dec 2005
$4.10 B(+16.0%)
$1.10 B(+4.2%)
$4.09 B(+1.4%)
Sept 2005
-
$1.05 B(+2.6%)
$4.03 B(+4.7%)
June 2005
-
$1.03 B(+12.4%)
$3.85 B(+4.9%)
Mar 2005
-
$912.77 M(-12.3%)
$3.67 B(+3.6%)
Dec 2004
$3.53 B(+21.2%)
$1.04 B(+19.2%)
$3.55 B(+41.5%)
Sept 2004
-
$873.13 M(+3.2%)
$2.51 B(+53.5%)
June 2004
-
$845.81 M(+7.5%)
$1.63 B(+107.5%)
Mar 2004
-
$786.46 M
$786.46 M
Dec 2003
$2.92 B(+23.6%)
-
-
Dec 2002
$2.36 B(+10.5%)
-
-
Dec 2001
$2.13 B(+4.7%)
-
-
Dec 2000
$2.04 B(+10.9%)
-
-
Dec 1999
$1.84 B(+17.8%)
-
-
Dec 1998
$1.56 B(-16.2%)
-
-
Dec 1997
$1.86 B(+0.4%)
-
-
Dec 1996
$1.85 B(+4.9%)
-
-
Dec 1995
$1.77 B(+15.7%)
-
-
Dec 1994
$1.53 B(+46.7%)
-
-
Dec 1993
$1.04 B(-23.0%)
-
-
Dec 1992
$1.35 B(+71.3%)
-
-
Dec 1991
$789.15 M(+15.8%)
-
-
Dec 1990
$681.45 M(+29.0%)
-
-
Dec 1989
$528.06 M(+21.8%)
-
-
Dec 1988
$433.72 M(+21.6%)
-
-
Dec 1987
$356.81 M(+222.1%)
-
-
Dec 1986
$110.76 M(-44.2%)
-
-
Dec 1985
$198.34 M(+17.0%)
-
-
Dec 1984
$169.47 M
-
-

FAQ

  • What is Novo Nordisk A/S annual gross profit?
  • What is the all time high annual gross profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual gross profit year-on-year change?
  • What is Novo Nordisk A/S quarterly gross profit?
  • What is the all time high quarterly gross profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly gross profit year-on-year change?
  • What is Novo Nordisk A/S TTM gross profit?
  • What is the all time high TTM gross profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM gross profit year-on-year change?

What is Novo Nordisk A/S annual gross profit?

The current annual gross profit of NVO is $28.53 B

What is the all time high annual gross profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual gross profit is $28.53 B

What is Novo Nordisk A/S annual gross profit year-on-year change?

Over the past year, NVO annual gross profit has changed by +$7.48 B (+35.51%)

What is Novo Nordisk A/S quarterly gross profit?

The current quarterly gross profit of NVO is $8.84 B

What is the all time high quarterly gross profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly gross profit is $8.84 B

What is Novo Nordisk A/S quarterly gross profit year-on-year change?

Over the past year, NVO quarterly gross profit has changed by +$1.68 B (+23.53%)

What is Novo Nordisk A/S TTM gross profit?

The current TTM gross profit of NVO is $33.32 B

What is the all time high TTM gross profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM gross profit is $33.32 B

What is Novo Nordisk A/S TTM gross profit year-on-year change?

Over the past year, NVO TTM gross profit has changed by +$7.38 B (+28.45%)